Alps Advisors Inc. Raises Stock Position in Exponent, Inc. $EXPO

Alps Advisors Inc. raised its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 65.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 120,306 shares of the business services provider’s stock after purchasing an additional 47,640 shares during the period. Alps Advisors Inc.’s holdings in Exponent were worth $8,359,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Norges Bank purchased a new position in Exponent in the 2nd quarter valued at about $43,752,000. First Trust Advisors LP purchased a new position in shares of Exponent in the second quarter valued at approximately $18,377,000. Bamco Inc. NY boosted its stake in shares of Exponent by 49.9% in the second quarter. Bamco Inc. NY now owns 501,239 shares of the business services provider’s stock worth $37,448,000 after acquiring an additional 166,930 shares during the last quarter. Geneva Capital Management LLC increased its position in shares of Exponent by 7.6% during the second quarter. Geneva Capital Management LLC now owns 1,877,765 shares of the business services provider’s stock worth $140,288,000 after purchasing an additional 131,937 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in Exponent by 25.1% in the 2nd quarter. JPMorgan Chase & Co. now owns 638,081 shares of the business services provider’s stock valued at $47,671,000 after purchasing an additional 128,131 shares during the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent News Summary

Here are the key news stories impacting Exponent this week:

• Positive Sentiment: Q4 results beat on both EPS and revenue — Exponent reported $0.49 EPS vs. $0.47 consensus and revenue of $147.4M vs. ~$128.5M est; revenue was up 4.5% YoY and margins/ROE remain healthy, signaling profitable growth that supports higher valuation multiples. Exponent Reports Fourth Quarter and Fiscal Year 2025 Financial Results
• Positive Sentiment: Management set targets for high single‑digit revenue growth and margin expansion in 2026, citing AI‑driven demand for services — this forward guidance lifts growth expectations and gives investors a reason to re-rate the stock. Exponent outlines high single-digit revenue growth and margin expansion targets for 2026 amid AI-driven demand
• Positive Sentiment: Dividend increased to $0.31 quarterly (3.3% bump) — management’s raise and continued payout signal confidence in cash flow and return of capital to shareholders, supporting investor sentiment. Exponent Increases Quarterly Dividend Payment from $0.30 to $0.31 per Share for Q1 2026
• Positive Sentiment: Strategic bolt‑on: Exponent acquired the international region of Optimas Solutions (Optimas will operate independently), which can broaden service footprint and client exposure outside the U.S. — a modest inorganic growth catalyst. Optimas Solutions to Operate as Independent Business Following Sale of International Region to Exponent
• Neutral Sentiment: Full earnings call transcripts and coverage are available (Yahoo, Seeking Alpha, Zacks, SFGate) for investors wanting details on client demand, utilization, and margin levers — useful for modeling but not new catalysts by themselves. Exponent (EXPO) Q4 2025 Earnings Call Transcript

Exponent Price Performance

NASDAQ:EXPO opened at $79.79 on Monday. The company’s 50-day moving average is $73.00 and its two-hundred day moving average is $70.96. Exponent, Inc. has a 1-year low of $63.81 and a 1-year high of $97.57. The firm has a market capitalization of $3.98 billion, a price-to-earnings ratio of 38.36 and a beta of 0.79.

Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Thursday, February 5th. The business services provider reported $0.49 EPS for the quarter, beating the consensus estimate of $0.47 by $0.02. The firm had revenue of $147.43 million for the quarter, compared to analyst estimates of $128.48 million. Exponent had a net margin of 18.21% and a return on equity of 25.51%. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.46 EPS. As a group, equities analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent announced that its board has initiated a share repurchase plan on Thursday, October 30th that authorizes the company to repurchase $100.00 million in outstanding shares. This repurchase authorization authorizes the business services provider to repurchase up to 3% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

Exponent Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 20th. Stockholders of record on Friday, March 6th will be issued a dividend of $0.31 per share. The ex-dividend date is Friday, March 6th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.6%. This is a boost from Exponent’s previous quarterly dividend of $0.30. Exponent’s dividend payout ratio (DPR) is currently 57.69%.

Insider Activity

In related news, CEO Catherine Corrigan sold 1,663 shares of the business’s stock in a transaction dated Thursday, January 15th. The shares were sold at an average price of $72.52, for a total value of $120,600.76. Following the sale, the chief executive officer directly owned 92,723 shares in the company, valued at approximately $6,724,271.96. The trade was a 1.76% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Over the last three months, insiders sold 9,788 shares of company stock worth $693,648. 1.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

EXPO has been the subject of a number of research reports. William Blair raised shares of Exponent from a “market perform” rating to an “outperform” rating in a report on Monday, November 17th. JPMorgan Chase & Co. assumed coverage on shares of Exponent in a report on Monday, January 26th. They issued an “overweight” rating and a $100.00 price objective for the company. Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a report on Thursday, January 22nd. Finally, UBS Group reaffirmed a “neutral” rating and issued a $81.00 price target (up previously from $76.00) on shares of Exponent in a report on Monday, December 15th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $90.50.

Exponent Profile

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.